Internal Medicine · Brooklyn, NY
NPI
1558313932
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
1508 Avenue U
Brooklyn, NY, 11229
Phone (718) 376-3383
Groups this clinician bills Medicare through
Medicare paid, 2024
$38K
714 services
Medicare patients, 2024
60
Average age 75
Drug cost, 2024
$2.3M
17,006 prescriptions
Company payments, 2025
$2,596
From 19 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Robin Y Chan was code 99497 (care management/coordination), 105 times for 54 patients. In total Robin Y Chan billed 714 services in 38 codes, and Medicare paid $38K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-02-28.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99497 Care Management/Coordination | Office | 105 | 54 | $71.50 | $7,507 |
| 99214 Office E&M - Established | Office | 101 | 38 | $110.55 | $11K |
| 99213 Office E&M - Established | Office | 63 | 33 | $74.34 | $4,683 |
| G0136 Administration of a standardized, evidence-based social determinants of health risk assessment tool, 5-15 minutes | Office | 49 | 39 | $15.96 | $782 |
| G0442 Annual alcohol misuse screening, 5 to 15 minutes | Office | 38 | 38 | $21.71 | $825 |
| 96127 Behavioral Health Services | Office | 35 | 15 | $4.55 | $159 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 34 | 34 | $147.27 | $5,007 |
| G0444 Annual depression screening, 5 to 15 minutes | Office | 28 | 28 | $21.64 | $606 |
| 96160 E&M - Miscellaneous | Office | 26 | 24 | $2.71 | $70.5 |
| G0446 Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | Office | 24 | 24 | $28.27 | $679 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 23 | 15 | $13.88 | $319 |
| G0008 Administration of influenza virus vaccine | Office | 22 | 22 | $37.09 | $816 |
| 93000 Electrocardiogram | Office | 22 | 20 | $13.20 | $290 |
| 36415 Venipuncture Blood Collection | Office | 15 | 15 | $8.65 | $130 |
| 90662 Vaccine Product | Office | 12 | 12 | $81.00 | $972 |
By year: 2022 $49K for 801 services; 2023 $35K for 541 services; 2024 $38K for 714 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 15 | 15 | $8.65 | $130 |
Medicare prescription drug claims, 2024
In 2024, the drug Robin Y Chan prescribed most often to Medicare patients was Vascepa (Icosapent Ethyl), with 698 prescriptions and refills. In total Robin Y Chan wrote 17,006 Medicare prescriptions that cost $2.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Vascepa Icosapent Ethyl | 698 | 892 | 104 | $230K |
| Rosuvastatin Calcium Generic | 666 | 1,546 | 164 | $6,533 |
| Amlodipine Besylate Generic | 636 | 1,549 | 165 | $5,061 |
| Diclofenac Sodium Generic | 396 | 423 | 126 | $68K |
| Simvastatin Generic | 367 | 890 | 86 | $2,757 |
| Losartan Potassium Generic | 365 | 948 | 101 | $3,475 |
| Ammonium Lactate Generic | 339 | 359 | 86 | $9,415 |
| Pantoprazole Sodium Generic | 335 | 363 | 91 | $1,317 |
| Tamsulosin Hcl Generic | 333 | 633 | 67 | $3,901 |
| Alendronate Sodium Generic | 316 | 591 | 68 | $2,313 |
| Halobetasol Propionate Generic | 311 | 331 | 114 | $23K |
| Atorvastatin Calcium Generic | 303 | 747 | 95 | $2,628 |
| Celecoxib Generic | 299 | 317 | 80 | $2,930 |
| Montelukast Sodium Generic | 289 | 311 | 58 | $1,288 |
| Gabapentin Generic | 286 | 296 | 62 | $1,803 |
Brand drugs: 3,379 claims; generic drugs: 13,417 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Robin Y Chan $2,596 ($2,596 in general payments such as food, travel and fees) from 19 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $554.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 30 | $554 |
| Amgen Inc. AMGN | 10 | $403 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 8 | $223 |
| GlaxoSmithKline, LLC. GSK | 13 | $221 |
| Gilead Sciences, Inc. GILD | 9 | $206 |
| Pfizer Inc. PFE | 8 | $198 |
| Esperion Therapeutics, Inc. ESPR | 8 | $137 |
| Insmed, Inc. INSM | 4 | $103 |
| Novo Nordisk Inc NVO | 6 | $87.38 |
| Shield Therapeutics Inc STX.L | 4 | $74.12 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.